ABOS Stock Data and Insider Activity
ABOS - Acumen Pharmaceuticals, Inc. Common Stock Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.
  
     
Chart and Financial Data provided by TradingView
Whale Activity

Recently reported position changes by institutional investors

Senate Trading

Recent trades by U.S. Senators

No data for this ticker
House Trading

Recent trades by U.S. Representatives

No data for this ticker
Insider Trading

Quarterly net insider trading by a company's directors and management

No data for this ticker
Corporate Flights

Flights by private jets registered to ABOS

No data for this ticker
Government Contracts

Federal grants, loans, and purchases. Click on a date for more info.

No data for this ticker
WallStreetBets
Number of mentions of ABOS in WallStreetBets Daily Discussion
Date Mentions
9/29/2022 1
U.S. Patents

New patents grants by month

No data for this ticker
Off-Exchange Trading

Yesterday's off-exchange activity

No data for this ticker
Corporate Lobbying

Government lobbying spending instances

No data for this ticker
CNBC Recommendations

Recent picks made for ABOS on CNBC

No data for this ticker
Top ETF Holders

ETFs with the largest estimated holdings in ABOS

ETF Ticker ETF Name Est. Holding Size
VTI Vanguard $2.6 million
VXF Vanguard $1.1 million
IBB iShares $817256
IWC iShares $225703
DFAU Dimensional $21130
BIB ProShares $11574
DFAC Dimensional $8513
IBBQ Invesco $2301